AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2813153 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen 100 mg
Number of subjects: 88
Study 2813153 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 600 mg
Number of subjects: 88
Study 2813153 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 600 mg with Codeine 60 mg
Number of subjects: 88
Study 2813153 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study 1096923 — intervention group
Group type: EXPERIMENTAL
Intervention: Azaribine at 200 mg/kg a day
Number of subjects: 0
Study 1096923 — intervention group
Group type: EXPERIMENTAL
Intervention: Azaribine at 125 mg/kg a day
Number of subjects: 0
Study 31342886 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-fortified salt (DFS)
Number of subjects: 0
Study 31342886 — intervention group
Group type: COMPARATOR
Intervention: Iodized salt (Control)
Number of subjects: 0
Study 31342886 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline serum ferritin (sFt)
Number of subjects: 0
Study 31342886 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group
Number of subjects: 0
Study 31342886 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline body iron (BI)
Number of subjects: 0
Study 27655703 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical or palpation-guided biopsy
Number of subjects: 228
Study 27655703 — intervention group
Group type: COMPARATOR
Intervention: CT-guided biopsy
Number of subjects: 228
Study 27655703 — intervention group
Group type: COMPARATOR
Intervention: Ongoing chemotherapy
Number of subjects: 228
Study 27655703 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsy location (lymph nodes/soft tissue)
Number of subjects: 228
Study 27655703 — intervention group
Group type: COMPARATOR
Intervention: Biopsy location (lung)
Number of subjects: 228
Study 27655703 — intervention group
Group type: EXPERIMENTAL
Intervention: Differential attenuation (HU)
Number of subjects: 228
Study 26003280 — intervention group
Group type: EXPERIMENTAL
Intervention: HSV‐2 genital reactivation
Number of subjects: 14
Study 22632171 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced MI training program (3.5-day workshop, systematic feedback, and four sessions of supervision)
Number of subjects: 36
Study 22632171 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced MI training program
Number of subjects: 36
Study 22071709 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human leptin (rhleptin) infusion for 4 hours
Number of subjects: 16
Study 22071709 — intervention group
Group type: COMPARATOR
Intervention: Saline (control) infusion for 4 hours
Number of subjects: 16
Study 19192474 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefazodone
Number of subjects: 429
Study 19192474 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Analysis System of Psychotherapy (CBASP)
Number of subjects: 429
Study 19192474 — intervention group
Group type: COMPARATOR
Intervention: Medication (Nefazodone)
Number of subjects: 429
Study 19192474 — intervention group
Group type: COMPARATOR
Intervention: Psychotherapy (CBASP)
Number of subjects: 429
Study 16792767 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus ointment 0.1% applied twice daily
Number of subjects: 60
Study 16792767 — intervention group
Group type: COMPARATOR
Intervention: Standard moisturizers with SPF 20 sunscreen
Number of subjects: 60
Study 15327610 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic uterine nerve ablation (LUNA)
Number of subjects: 123
Study 15327610 — intervention group
Group type: COMPARATOR
Intervention: No LUNA
Number of subjects: 123
Study 15327610 — intervention group
Group type: EXPERIMENTAL
Intervention: LUNA with laparoscopic surgical treatment of endometriosis
Number of subjects: 123
Study 15327610 — intervention group
Group type: COMPARATOR
Intervention: No LUNA with laparoscopic surgical treatment of endometriosis
Number of subjects: 123
Study 15327610 — intervention group
Group type: EXPERIMENTAL
Intervention: LUNA
Number of subjects: 123
Study 11131930 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (50 mg once daily)
Number of subjects: 203
Study 11131930 — intervention group
Group type: COMPARATOR
Intervention: Captopril (50 mg three times daily)
Number of subjects: 203
Study 8937934 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (50 mg daily)
Number of subjects: 11
Study 8937934 — intervention group
Group type: EXPERIMENTAL
Intervention: Celiprolol (200 mg daily)
Number of subjects: 11
Study 8937934 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril (2.5 mg daily)
Number of subjects: 11
Study 8937934 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 1530170 — intervention group
Group type: COMPARATOR
Intervention: Propofol/N2O (Group II)
Number of subjects: 91
Study 1530170 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane/N2O (Group I)
Number of subjects: 91
Study 1530170 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane/O2 (Group IV)
Number of subjects: 91
Study 1530170 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane/N2O (Group III)
Number of subjects: 91
Study 4004381 — intervention group
Group type: EXPERIMENTAL
Intervention: Truncal vagotomy with Bilroth II gastrectomy
Number of subjects: 66
Study 4004381 — intervention group
Group type: COMPARATOR
Intervention: Encouragement to abstain from alcohol (Control)
Number of subjects: 66
Study 3479329 — intervention group
Group type: EXPERIMENTAL
Intervention: Adriamycin (ADM) 75 mg/m2 every 3 weeks
Number of subjects: 167
Study 3479329 — intervention group
Group type: COMPARATOR
Intervention: 4-epiadriamycin (EPI) 75 mg/m2 every 3 weeks
Number of subjects: 167
Study 31205121 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured cognitive training (6 weeks)
Number of subjects: 105
Study 31205121 — intervention group
Group type: EXPERIMENTAL
Intervention: Unstructured brain jogging (6 weeks)
Number of subjects: 105
Study 31205121 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 105
Study 28403472 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion regulation treatment combined with standard cognitive-behavioral smoking cessation (ERT + CBT)
Number of subjects: 70
Study 28403472 — intervention group
Group type: COMPARATOR
Intervention: Health and lifestyle plus standard smoking cessation active control (HLS + CBT)
Number of subjects: 70
Study 26577919 — intervention group
Group type: EXPERIMENTAL
Intervention: 33 °C
Number of subjects: 939
Study 26577919 — intervention group
Group type: COMPARATOR
Intervention: 36 °C
Number of subjects: 939
Study 23785038 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized reading instruction for 1, 2, or 3 years
Number of subjects: 0
Study 23785038 — intervention group
Group type: COMPARATOR
Intervention: Treated control condition intervention focused on mathematics
Number of subjects: 0
Study 21513917 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) intervention
Number of subjects: 106
Study 21513917 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 106
Study 18498953 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 322
Study 18498953 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 322
Study 16291802 — intervention group
Group type: EXPERIMENTAL
Intervention: fMRI signal changes in the posterior parietal cortex (PPC) during memory of target locations; no specific dosage or duration mentioned.
Number of subjects: 0
Study 16291802 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory of two sequentially flashed targets presented in either the same or different visual hemifields; no specific dosage or duration mentioned.
Number of subjects: 0
Study 12702116 — intervention group
Group type: EXPERIMENTAL
Intervention: Test abutments with varying surface roughness
Number of subjects: 9
Study 12702116 — intervention group
Group type: COMPARATOR
Intervention: Control group (original abutments)
Number of subjects: 9
Study 10986206 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 792
Study 10986206 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 150 mg
Number of subjects: 792
Study 10986206 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 10 mg
Number of subjects: 792
Study 10986206 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 20 mg
Number of subjects: 792
Study 8715781 — intervention group
Group type: EXPERIMENTAL
Intervention: Soothing music played during dinner for two weeks
Number of subjects: 0
Study 8715781 — intervention group
Group type: EXPERIMENTAL
Intervention: Swedish tunes from the 1920s and 1930s played during dinner for two weeks
Number of subjects: 0
Study 8715781 — intervention group
Group type: EXPERIMENTAL
Intervention: Pop music played during dinner for two weeks
Number of subjects: 0
Study 8715781 — intervention group
Group type: COMPARATOR
Intervention: No music for one week prior to music interventions
Number of subjects: 0
Study 8715781 — intervention group
Group type: COMPARATOR
Intervention: Control period of two weeks after music interventions
Number of subjects: 0
Study 1426317 — intervention group
Group type: EXPERIMENTAL
Intervention: Human recombinant GH (24 IU)
Number of subjects: 54
Study 1426317 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 2412829 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin adhesive (Tisseel)
Number of subjects: 16
Study 2412829 — intervention group
Group type: COMPARATOR
Intervention: Dexon sutures
Number of subjects: 16
Study 31473392 — intervention group
Group type: EXPERIMENTAL
Intervention: Real ionization air purification
Number of subjects: 44
Study 31473392 — intervention group
Group type: COMPARATOR
Intervention: Sham purification (control)
Number of subjects: 44
Study 29193576 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive servo-ventilation (ASV)
Number of subjects: 312
Study 29193576 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 312
Study 27566635 — intervention group
Group type: EXPERIMENTAL
Intervention: NIRF imaging laparoscopic cholecystectomy (NIRF‐LC)
Number of subjects: 308
Study 27566635 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopic cholecystectomy (CLC)
Number of subjects: 308
Study 24999076 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive antihypertensive treatment aiming for a target systolic blood pressure of 120-140 mmHg
Number of subjects: 200
Study 24999076 — intervention group
Group type: COMPARATOR
Intervention: Conservative antihypertensive treatment as recommended by guidelines for 7 days
Number of subjects: 200
Study 24999076 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive antihypertensive treatment
Number of subjects: 200
Study 24999076 — intervention group
Group type: COMPARATOR
Intervention: Conservative antihypertensive treatment
Number of subjects: 200
Study 22859825 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 doses of quadrivalent human papillomavirus vaccine (QHPV)
Number of subjects: 100
Study 22859825 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 doses of quadrivalent human papillomavirus vaccine (QHPV)
Number of subjects: 100
Study 20392870 — intervention group
Group type: EXPERIMENTAL
Intervention: PTH 1‐34
Number of subjects: 12
Study 20392870 — intervention group
Group type: COMPARATOR
Intervention: Calcitriol
Number of subjects: 12
Study 18514933 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga treatment (YT)
Number of subjects: 19
Study 18514933 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy (MT)
Number of subjects: 19
Study 16200819 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate (200 microg once daily)
Number of subjects: 123
Study 16200819 — intervention group
Group type: COMPARATOR
Intervention: Levocabastine hydrochloride (200 microg twice daily)
Number of subjects: 123
Study 16200819 — intervention group
Group type: COMPARATOR
Intervention: Disodium cromoglycate (5.6 mg 4 times daily)
Number of subjects: 123
Study 12109768 — intervention group
Group type: EXPERIMENTAL
Intervention: Central concepts in narrative texts
Number of subjects: 0
Study 12109768 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral concepts in script-based texts
Number of subjects: 0
Study 12109768 — intervention group
Group type: EXPERIMENTAL
Intervention: Central concepts in script-based texts
Number of subjects: 0
Study 9475262 — intervention group
Group type: EXPERIMENTAL
Intervention: molsidomine (6 mg/h)
Number of subjects: 15
Study 9475262 — intervention group
Group type: COMPARATOR
Intervention: isosorbide-5-mononitrate (3.75 mg/h)
Number of subjects: 15
Study 8574314 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive therapy aimed at increasing vocal and respiratory effort (VR)
Number of subjects: 22
Study 8574314 — intervention group
Group type: COMPARATOR
Intervention: Intensive therapy aimed at increasing respiratory effort (R)
Number of subjects: 22
Study 2677866 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemostatic sutures
Number of subjects: 200
Study 2677866 — intervention group
Group type: COMPARATOR
Intervention: Monsel's solution and vaginal pack (non-suture technique)
Number of subjects: 200
Study 389839 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg
Number of subjects: 60
Study 389839 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 160 mg
Number of subjects: 60
Study 389839 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 389839 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 160 mg vs Propranolol 80 mg
Number of subjects: 60
Study 30142886 — intervention group
Group type: EXPERIMENTAL
Intervention: ADF + DER
Number of subjects: 162
Study 30142886 — intervention group
Group type: COMPARATOR
Intervention: DER
Number of subjects: 162
Study 27131077 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily boost of 0.5 Gy to the tumor bed
Number of subjects: 400
Study 27131077 — intervention group
Group type: COMPARATOR
Intervention: Weekly boost of 2 Gy to the tumor bed
Number of subjects: 400
Study 24739135 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid revascularisation in patients with an ipsilateral foetal-type posterior cerebral artery
Number of subjects: 98
Study 24739135 — intervention group
Group type: COMPARATOR
Intervention: Carotid revascularisation in patients with a normal posterior cerebral artery
Number of subjects: 98
Study 22492586 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 50 mg QD
Number of subjects: 451
Study 22492586 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg QD
Number of subjects: 451
Study 22492586 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 200 mg QD
Number of subjects: 451
Study 22492586 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg QD
Number of subjects: 451
Study 22492586 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg BID
Number of subjects: 451
Study 22492586 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 451
Study 22492586 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg QD
Number of subjects: 451
Study 22492586 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 451
Study 19582490 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference valuation set for EQ-5D health states derived from the general Flemish public
Number of subjects: 548
Study 19582490 — intervention group
Group type: COMPARATOR
Intervention: Comparison with health state valuations from other countries
Number of subjects: 548
Study 17974534 — intervention group
Group type: EXPERIMENTAL
Intervention: Exacta small screw titanium implants (Exacta MS series conical profile, diameter 3.3 mm, length 7.0 mm)
Number of subjects: 16
Study 16330290 — intervention group
Group type: EXPERIMENTAL
Intervention: Glimepiride (titrated from 2 to 4 to 8 mg/d over 6 weeks, followed by 20 weeks of maintenance therapy)
Number of subjects: 170
Study 16330290 — intervention group
Group type: EXPERIMENTAL
Intervention: Glimepiride
Number of subjects: 170
Study 16330290 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 170
Study 16330290 — intervention group
Group type: COMPARATOR
Intervention: Glimepiride and Placebo
Number of subjects: 170
Study 11949926 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician mammography reminders
Number of subjects: 0
Study 9628124 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg L-846
Number of subjects: 11
Study 9628124 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg L-846
Number of subjects: 11
Study 7839093 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous omeprazole (40 mg three times daily, loading dose 80 mg) and amoxicillin (2 g three times daily for 3 days, then 20 mg omeprazole twice daily and 1 g amoxicillin twice daily orally for 11 days)
Number of subjects: 20
Study 7839093 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole (40 mg three times daily, loading dose 80 mg) intravenously for 3 days and 20 mg omeprazole twice daily and 1 g amoxicillin twice daily orally for 11 days
Number of subjects: 20
Study 3279756 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg at 6 PM
Number of subjects: 141
Study 3279756 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 300 mg at 10 PM
Number of subjects: 141
Study 31477542 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive TBS (3 intermittent TBS treatments per day for 3 days in week 1, 3 treatments a day for 2 days in week 2, and 3 treatments in 1 day in week 3 and in week 4)
Number of subjects: 74
Study 31477542 — intervention group
Group type: COMPARATOR
Intervention: Standard rTMS (5 daily sessions per week for 4 weeks)
Number of subjects: 74
Study 27455886 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Methotrexate (MTX) 7.5 mg twice or thrice weekly
Number of subjects: 135
Study 27455886 — intervention group
Group type: COMPARATOR
Intervention: Oral Methotrexate (MTX) 15 mg or 22.5 mg in a single dose weekly
Number of subjects: 135
Study 27455886 — intervention group
Group type: COMPARATOR
Intervention: Parenteral Methotrexate (MTX) 15 mg or 22.5 mg in a single dose weekly
Number of subjects: 135
Study 26354605 — intervention group
Group type: EXPERIMENTAL
Intervention: Sake yeast supplementation (500 mg of sake yeast powder)
Number of subjects: 68
Study 26354605 — intervention group
Group type: COMPARATOR
Intervention: Placebo (cellulose)
Number of subjects: 68
Study 26564511 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency ultrasound (HFUS) in slightly-painful group
Number of subjects: 24
Study 26564511 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency ultrasound (HFUS) in extremely-painful group
Number of subjects: 24
Study 26564511 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency ultrasound (HFUS) in painless group
Number of subjects: 24
Study 26564511 — intervention group
Group type: COMPARATOR
Intervention: Conventional clinical treatment evaluations
Number of subjects: 24
Study 24297959 — intervention group
Group type: EXPERIMENTAL
Intervention: Superelastic nickel-titanium archwires
Number of subjects: 85
Study 24297959 — intervention group
Group type: COMPARATOR
Intervention: Multistranded stainless steel archwires
Number of subjects: 85
Study 21593045 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 134
Study 21593045 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study 18398348 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril, 10 mg once daily for 24 weeks
Number of subjects: 40
Study 18398348 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 17067330 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulating catheter
Number of subjects: 76
Study 17067330 — intervention group
Group type: COMPARATOR
Intervention: Conventional catheter
Number of subjects: 76
Study 17067330 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulating catheter with 100-ml bags of ropivacaine 2 mg/ml
Number of subjects: 76
Study 17067330 — intervention group
Group type: COMPARATOR
Intervention: Conventional catheter with 100-ml bags of ropivacaine 2 mg/ml
Number of subjects: 76
Study 17067330 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulating catheter with 200-ml bags of ropivacaine 2 mg/ml
Number of subjects: 76
Study 17067330 — intervention group
Group type: COMPARATOR
Intervention: Conventional catheter with 200-ml bags of ropivacaine 2 mg/ml
Number of subjects: 76
Study 12807937 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 250 mg/m2
Number of subjects: 271
Study 12807937 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel 175 mg/m2
Number of subjects: 271
Study 12807937 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 250 mg/m2 with filgrastim 5 microg/kg
Number of subjects: 271
Study 12807937 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 250 mg/m2 with filgrastim 10 microg/kg
Number of subjects: 271
Study 12807937 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel 175 mg/m2 without filgrastim
Number of subjects: 271
Study 11140555 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine porous bone mineral with porcine derived collagen membrane
Number of subjects: 22
Study 11140555 — intervention group
Group type: COMPARATOR
Intervention: Open flap debridement
Number of subjects: 22
Study 9192506 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Electrical Stimulated (FES) upright cycling for 12 months, 30 min per day, 3 days per week
Number of subjects: 10
Study 9192506 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced training (one weekly session for 6 months)
Number of subjects: 10
Study 9192506 — intervention group
Group type: EXPERIMENTAL
Intervention: FES cycle training
Number of subjects: 10
Study 9192506 — intervention group
Group type: COMPARATOR
Intervention: Control group (age-matched individuals)
Number of subjects: 10
Study 7999161 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling pads at 40 degrees F
Number of subjects: 131
Study 7999161 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling pads at 45 degrees F
Number of subjects: 131
Study 7999161 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling pads at 55 degrees F
Number of subjects: 131
Study 7999161 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling pads at 70 degrees F
Number of subjects: 131
Study 7999161 — intervention group
Group type: COMPARATOR
Intervention: No cooling pads
Number of subjects: 131
Study 3069479 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg chlorambucil
Number of subjects: 5